BioCentury
ARTICLE | Clinical News

Berlex Laboratories regulatory update

May 15, 1995 7:00 AM UTC

Berlex's Ultravist (iopromide) injection received FDA approval as a nonionic contrast agent for x-ray imaging. The Wayne, N.J., company said Ultravisc, which is sold in 78 countries, will be available...